202 related articles for article (PubMed ID: 25227497)
21. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
[TBL] [Abstract][Full Text] [Related]
22. Treatment of spinal tumors using cyberknife fractionated stereotactic radiosurgery: pain and quality-of-life assessment after treatment in 200 patients.
Gagnon GJ; Nasr NM; Liao JJ; Molzahn I; Marsh D; McRae D; Henderson FC
Neurosurgery; 2009 Feb; 64(2):297-306; discussion 306-7. PubMed ID: 19057426
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.
Asai K; Shioyama Y; Nakamura K; Sasaki T; Ohga S; Nonoshita T; Yoshitake T; Ohnishi K; Terashima K; Matsumoto K; Hirata H; Honda H
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):768-73. PubMed ID: 22445398
[TBL] [Abstract][Full Text] [Related]
24. Pain flare, complexity and analgesia in bone oligometastases treated with stereotactic body radiation therapy.
Loi M; Klass ND; De Vries KC; Fleury E; Van Zwienen M; de Pree I; Nuyttens J
Eur J Cancer Care (Engl); 2018 Nov; 27(6):e12915. PubMed ID: 30246916
[TBL] [Abstract][Full Text] [Related]
25. Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases.
Chow E; Ling A; Davis L; Panzarella T; Danjoux C
Radiother Oncol; 2005 Apr; 75(1):64-9. PubMed ID: 15878102
[TBL] [Abstract][Full Text] [Related]
26. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
[TBL] [Abstract][Full Text] [Related]
27. Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life.
Jain S; Poon I; Soliman H; Keller B; Kim A; Lochray F; Yeung L; Cheung P
Radiother Oncol; 2013 Aug; 108(2):320-5. PubMed ID: 23993401
[TBL] [Abstract][Full Text] [Related]
28. Dexamethasone for the Prevention of a Pain Flare After Palliative Radiation Therapy for Painful Bone Metastases: The Multicenter Double-Blind Placebo-Controlled 3-Armed Randomized Dutch DEXA Study.
van der Linden YM; Westhoff PG; Stellato RK; van Baardwijk A; de Vries K; Ong F; Wiggenraad R; Bakri B; Wester G; de Pree I; van Veelen L; Budiharto T; Schippers M; Reyners AKL; de Graeff A
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):546-553. PubMed ID: 32446951
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
[TBL] [Abstract][Full Text] [Related]
30. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of stereotactic radiosurgery for tumors of the spine.
Benzil DL; Saboori M; Mogilner AY; Rocchio R; Moorthy CR
J Neurosurg; 2004 Nov; 101 Suppl 3():413-8. PubMed ID: 15537198
[TBL] [Abstract][Full Text] [Related]
32. [Stereotactic body radiation therapy (SBRT) for pain management in spine bone metastases].
Jara O N; Solé P C; Solé Z S
Rev Med Chil; 2019 Aug; 147(8):993-996. PubMed ID: 31859963
[TBL] [Abstract][Full Text] [Related]
33. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
Stephans KL; Djemil T; Tendulkar RD; Robinson CG; Reddy CA; Videtic GM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):974-80. PubMed ID: 21300453
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
Bradley JD; El Naqa I; Drzymala RE; Trovo M; Jones G; Denning MD
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1146-50. PubMed ID: 19800181
[TBL] [Abstract][Full Text] [Related]
35. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
[TBL] [Abstract][Full Text] [Related]
36. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
Tan DT; Chee SP; Lim L; Lim AS
Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis.
Haley ML; Gerszten PC; Heron DE; Chang YF; Atteberry DS; Burton SA
J Neurosurg Spine; 2011 Apr; 14(4):537-42. PubMed ID: 21314284
[TBL] [Abstract][Full Text] [Related]
38. Comparison of early complications for patients with convexity and parasagittal meningiomas treated with either stereotactic radiosurgery or fractionated stereotactic radiotherapy.
Girvigian MR; Chen JC; Rahimian J; Miller MJ; Tome M
Neurosurgery; 2008 May; 62(5 Suppl):A19-27; discussion A27-8. PubMed ID: 18580776
[TBL] [Abstract][Full Text] [Related]
39. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
[TBL] [Abstract][Full Text] [Related]
40. Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up.
Ning MS; Deegan BJ; Ho JC; Chapman BV; Bishop AJ; Allen PK; Tannir NM; Amini B; Briere TM; Wang XA; Tatsui CE; Rhines LD; Brown PD; Li J; Ghia AJ
Radiother Oncol; 2019 Sep; 138():80-85. PubMed ID: 31252298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
